Ntla stock forecast.
Dec 1, 2023 · NTLA is a biotech company that develops gene editing therapies for cancer and other diseases. The average price target for its stock is $82.19, with a range of $40 to $144, based on 21 analyst recommendations. The stock has a strong buy rating from 18 brokerage firms and a low of 40.00. The upside is 237.12%.
NTLA - Free Report) reported second-quarter 2023 loss of $1.40 per share, wider than the Zacks Consensus Estimate of a loss of $1.32. In the year-ago quarter, Intellia incurred a loss of $1.33 per ...There was a snowstorm in the Northeast this week. Or maybe that supposed storm was just a light dusting. It depends on who you ask. Having grown up in the mountains of Colorado, I am well aware at just how terrible these forecasts tend to b...Intellia Therapeutics (NTLA) Stock Forecast & Price Prediction. Estimation of the future price movement of Intellia Therapeutics stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis.Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance
Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceFind the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceIntellia's Q1 2023 financial report shows a cash position of $1.2 billion, with collaboration revenue rising to $12.6 million and a net loss of $103.1 million. The success of NTLA-2002 in further ...
Intellia Therapeutics (NASDAQ:NTLA) has observed the following analyst ratings within the last quarter: These 12 analysts have an average price target of $77.5 versus the current price of Intellia ...
Stock Price Forecast. The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +175.23% increase from the …May 10, 2023 · Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance NTLA Stock Forecast For Tomorrow, Week, Month. SRNE Stock Forecast 2023, 2024, 2025. Intellia Therapeutics stock price predictions for March 2024. The forecast for beginning of March 27.91. Maximum value 30.29, while minimum 26.87. Averaged Intellia Therapeutics stock price for month 28.41. Price at the end 28.58, change for March 2.40%.The average one-year price target for NTLA / Intellia Therapeutics Inc is $84.617. The forecasts range from a low of $38.38 to a high of $164.85. A stock’s price target is the price at which analysts consider it fairly valued with respect to …
Find the latest Intellia Therapeutics, Inc. NTLA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range …
A high-level overview of Intellia Therapeutics, Inc. (NTLA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
The stock market has always been a volatile environment – but the last several weeks have seen an increase in that phenomenon. The bull market of 2021 shifted into reverse in January, and increased intraday swings, along with a partial reversal of losses, have been the order of the day in February. Unsurprisingly, much of the market’s …Stock Price Forecast The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00.Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Discover historical prices for NTLA stock on Yahoo Finance. View daily, weekly or monthly format back to when Intellia Therapeutics, Inc. stock was issued.Three Fool.com contributors identified what they believe could be monster stocks in the making. Here's why these chose Axsome Therapeutics ( AXSM 0.90%), CRISPR Therapeutics ( CRSP -3.42%), and ...
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...A high-level overview of Intellia Therapeutics, Inc. (NTLA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.On today's stock market, NTLA stock skidded 3.8%, reversing from a premarket climb and closing at 27.96. Shares of Regeneron Pharmaceuticals ( REGN ), which is collaborating with Intellia on the ...Track Intellia Therapeutics Inc (NTLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFind the latest Intellia Therapeutics, Inc. NTLA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.
Get the latest Direxion Daily Small Cap Bull 3X ETF (TNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...
Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.Dec 1, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... Nov 30, 2023 · Stock Price Forecast. According to 20 stock analysts, the average 12-month stock price forecast for NTLA stock stock is $77.4, which predicts an increase of 149.44%. The lowest target is $39 and the highest is $136. On average, analysts rate NTLA stock stock as a buy. Verve Therapeutics Inc () Stock Market info Recommendations: Buy or sell Verve Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Verve Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Verve Therapeutics's VERV shares and potentially its …Intellia Therapeutics (NASDAQ: NTLA) stock represents a company utilizing CRISPR/Cas9, a powerful tool for precisely and efficiently editing genetic sequences.The company is using this technology ...Cathie Wood and Wall Street analysts aren't always on the same page. Analysts are bearish, for example, on the three stocks that have helped the most in Wood's Ark Innovation ETF (ARKK 1.26% ...
Analysts have provided the following ratings for Intellia Therapeutics (NASDAQ:NTLA) within the last quarter: These 9 analysts have an average price target of $70.78 versus the current price of ...
14,305.03 +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil -1.56(-2.05%) Gold 2,091.00 +33.80(+1.64%) Advertisement Intellia Therapeutics, Inc. (NTLA) NasdaqGM - NasdaqGM Real Time Price....
What are analysts forecasts for Intellia Therapeutics stock? The 61 analysts offering price forecasts for Intellia Therapeutics have a median target of 93.70, with a high estimate of 180.00 and a ...Intellia Therapeutics ( NASDAQ: NTLA) added ~13% on Thursday to reach the highest level in more than two months after the gene-editing company reported its Q1 2023 financials alongside updates ...The current Intellia Therapeutics [ NTLA] share price is $28.76. The Score for NTLA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels. Future criteria checks 2/6. Intellia Therapeutics is forecast to grow earnings and revenue by 6.3% and 57.2% per annum respectively. EPS is expected to grow by 11.3% per annum. Return on equity is forecast to be -20.1% in 3 years.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Intellia Therapeutics, Inc. (NTLA) : Free Stock Analysis Report. To read this article on Zacks.com click ...The stock market has always been a volatile environment – but the last several weeks have seen an increase in that phenomenon. The bull market of 2021 shifted into reverse in January, and increased intraday swings, along with a partial reversal of losses, have been the order of the day in February. Unsurprisingly, much of the market’s …Dosed first patient in the global Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE)Expects to complete enrollment in the Phase 2 study of NTLA-2002 in 2H 2023Plans to ...Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s ( NTLA) price is currently up 15.63% so far this month. During the month of May, Intellia Therapeutics Inc’s stock price has reached a high of $44.21 and a low of $36.89. Over the last year, Intellia Therapeutics Inc has hit prices as high as $76.45 and as low as $32.44.Nov 30, 2023 · The average twelve-month price prediction for Intellia Therapeutics is $77.70 with a high price target of $136.00 and a low price target of $40.00. Learn more on NTLA's analyst rating history. Do Wall Street analysts like Intellia Therapeutics more than its competitors?
Intellia Therapeutics has recently been granted FDA clearance to include the United States in the global Phase 2 portion of its Phase 1/2 study for NTLA-2002. This is a significant milestone for ...NTNX one year forecast. Nutanix stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast NTNX stock forecast for 2023 – 2027. Last updated: November 16, 2023. Are you interested in Nutanix, Inc. stocks prediction? ... NTLA Stock Forecast; NTIP Stock Forecast;Track Intellia Therapeutics Inc (NTLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsInstagram:https://instagram. washington mutual fundenergy fundersstock drip calculatornasdaq cara Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners. pink etfstock sbux Intellia Therapeutics (NTLA) Stock Forecast & Price Prediction. Estimation of the future price movement of Intellia Therapeutics stock, based on various factors such as … realty income stock dividend Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Intellia was founded in 2014 and went public in 2016, raising net proceeds of $112.1 million at $18 per share. The stock currently trades around $36.00 a share, translating to a market cap of $3. ...Earnings vs Market: NTLA is forecast to remain unprofitable over the next 3 years. High Growth Earnings : NTLA is forecast to remain unprofitable over the next 3 …